EVX Ventures


EVX Ventures is a global investor focused on the life sciences and healthcare sectors, with a mission to invest in life sciences ventures and support their growth to create a lasting impact worldwide. Based in key hubs like Singapore and Shanghai, the firm leverages extensive global networks to foster cross-border ecosystems and drive innovation. EVX Ventures is dedicated to backing visionary entrepreneurs and transformative technologies to propel them to success.

EVX Ventures

EVX Ventures

Blk 5014 Ang Mo Kio Avenue 5, Techplace II, Singapore 569881


What We Do

EVX Nexus provides biotech companies a comprehensive, one-stop co-working space with a fully integrated laboratory, dedicated tissue culture and private suites, state-of-the-art equipment, private meeting rooms, and supportive operational and service team. It serves as a bridge between science and medicine, facilitating collaboration within the biomedical community.

The Morphosis fellowship aims to nurture and build talent in the biotech ecosystem by providing transformative training for individuals passionate about translating discoveries into new biotech ventures. It offers immersive projects, interactive discussions, and exclusive masterclasses from global leaders.



Portfolio

AltruBio is a clinical-stage biotech company focused on developing novel antibody therapeutics for immunological diseases with high unmet medical needs.

#Biotechnology

Carcell Biopharma develops next-generation cell and gene therapies, with platforms around engineered red blood cells for immuno-modulation and non-viral gene delivery using lipid nanoparticles.

#Biotechnology

Carmine Therapeutics is pioneering a new class of genetic medicines based on engineered red blood cells extracellular vesicles (RBCEVs).

#Biotechnology

Hummingbird Bioscience focuses on the discovery and early development of oncology drugs.

#Biotechnology

Jotbody is dedicated to offering single domain antibody (sdAb) discovery services and sdAb-based research reagents.

#Biotechnology

Lerna Biopharma is developing RNA therapeutics for patients with liver diseases.

#Biotechnology

Nuevocor focuses on developing AAV gene therapy vectors for genetically defined cardiac diseases.

#Biotechnology

PairX Bio develops next-generation cancer immunotherapies targeting shared tumor-associated antigens derived from aberrantly spliced proteins.

#Biotechnology


Key People

Chairman/Managing Director

Managing Director

Operations Manager

LinkedIn

Senior Associate

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.